EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Cost-Effectiveness Analysis of PCSK9 Inhibitors in Patients with Atherosclerotic Cardiovascular Disease Without Prior Ischemic Events in Italy

Giuseppe Musumeci, Lorenzo Pradelli, Kelly Lee, Massimiliano Povero

Clinical Drug Investigation · 2026-07 · 46 (7) · 771-782

DOI: 10.1007/s40261-026-01559-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Drug Investigation, online erschienen am 12.05.2026. Verfasst von Giuseppe Musumeci und 3 weiteren Autor:innen. Beteiligte Einrichtung: Struttura Complessa di Cardiologia, Azienda Ospedaliera Ordine Mauriziano, Turin, Italy. Hauptthemen laut MEDLINE: PCSK9 Inhibitors, Atherosclerosis, Anticholesteremic Agents, Antibodies, Monoclonal. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PCSK9 InhibitorsAtherosclerosisAnticholesteremic AgentsAntibodies, MonoclonalCardiovascular DiseasesHumansCost-Benefit AnalysisItalyCost-Effectiveness AnalysisMarkov ChainsProprotein Convertase 9FemaleMaleAgedEzetimibeHydroxymethylglutaryl-CoA Reductase InhibitorsMiddle AgedDrug Therapy, Combination

Substanzen

PCSK9 InhibitorsPCSK9 protein, humanProprotein Convertase 9Anticholesteremic AgentsAntibodies, MonoclonalEzetimibeHydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Struttura Complessa di Cardiologia, Azienda Ospedaliera Ordine Mauriziano, Turin, Italy.
  • AdRes HE&OR, Turin, Italy.
  • Department of General Medicines and Market Access, Sanofi, Reading, UK.
  • AdRes HE&OR, Turin, Italy. m.povero@adreshe.com.

Zitieren

APA

Musumeci, G., Pradelli, L., Lee, K., & Povero, M. (2026). Cost-Effectiveness Analysis of PCSK9 Inhibitors in Patients with Atherosclerotic Cardiovascular Disease Without Prior Ischemic Events in Italy. Clinical Drug Investigation, 46(7), 771-782. https://doi.org/10.1007/s40261-026-01559-7

Vancouver

Musumeci G, Pradelli L, Lee K, Povero M. Cost-Effectiveness Analysis of PCSK9 Inhibitors in Patients with Atherosclerotic Cardiovascular Disease Without Prior Ischemic Events in Italy. Clinical Drug Investigation. 2026;46(7):771-782. doi:10.1007/s40261-026-01559-7

BibTeX
@article{Musumeci2026,
  author = {Musumeci, Giuseppe and Pradelli, Lorenzo and Lee, Kelly and Povero, Massimiliano},
  title = {Cost-Effectiveness Analysis of PCSK9 Inhibitors in Patients with Atherosclerotic Cardiovascular Disease Without Prior Ischemic Events in Italy},
  journal = {Clinical Drug Investigation},
  year = {2026},
  volume = {46},
  number = {7},
  pages = {771--782},
  doi = {10.1007/s40261-026-01559-7}
}
Kostenlos starten →